Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in more than 75 countries, we are proud to have reached millions of people with our products.
Citric Acid Monohydrate, Lysine Hydrochloride (stabilizer, 25.55 mg), Polysorbate 80, Trehalose Dihydrate (stabilizer, 105.0 mg), Sodium Hydroxide[IV Solution Stabilizer] 1 vial (10 mL) containsCitric Acid Monohydrate (52.5 mg), Lysine Hydrochloride (2283.8 mg), Polysorbate 80 (10 mg), Sodium Hydroxide (q.s.), Water For Injection (q.s.)
1. MRD-positive B-cell Precursor ALL
THIS DRUG is indicated for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1% in adults and children.
2. Relapsed or Refractory B cell Precursor ALL
THIS DRUG is indicated for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children.